Healthcare provider profile · identity verified

Pooja Madan, MD

Family Practice · MILWAUKEE, WI · NPI 1972732170

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	364	99
Atorvastatin Calcium	Atorvastatin Calcium	349	107
Losartan Potassium	Losartan Potassium	311	77
Lisinopril	Lisinopril	173	44
Levothyroxine Sodium	Levothyroxine Sodium	170	42
Metformin Hcl	Metformin Hcl	151	39
Omeprazole	Omeprazole	143	39
Albuterol Sulfate Hfa	Albuterol Sulfate	140	59
Hydrochlorothiazide	Hydrochlorothiazide	137	36
Rosuvastatin Calcium	Rosuvastatin Calcium	137	44
Pantoprazole Sodium	Pantoprazole Sodium	125	32
Pravastatin Sodium	Pravastatin Sodium	125	26
Potassium Chloride	Potassium Chloride	118	29
Metoprolol Succinate	Metoprolol Succinate	115	32
Allopurinol	Allopurinol	96	20
Gabapentin	Gabapentin	93	26
Famotidine	Famotidine	89	25
Metformin Hcl Er	Metformin Hcl	85	20
Ezetimibe	Ezetimibe	81	25
Sertraline Hcl	Sertraline Hcl	78	21
Trazodone Hcl	Trazodone Hcl	76	21
Spironolactone	Spironolactone	73	21
Tizanidine Hcl	Tizanidine Hcl	70	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	suppressed
Fluticasone Propionate	Fluticasone Propionate	65	24
Furosemide	Furosemide	64	23
Chlorthalidone	Chlorthalidone	63	15
Eliquis	Apixaban	63	17
Simvastatin	Simvastatin	56	15
Jardiance	Empagliflozin	55	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	16
Sumatriptan Succinate	Sumatriptan Succinate	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	11
Clopidogrel	Clopidogrel Bisulfate	48	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	48	14
Montelukast Sodium	Montelukast Sodium	47	11
Ozempic	Semaglutide	46	14
Mirtazapine	Mirtazapine	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	13
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	40	11
Warfarin Sodium	Warfarin Sodium	38	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Topiramate	Topiramate	36	suppressed
Lovastatin	Lovastatin	35	11
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Carvedilol	Carvedilol	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	11
Hydrocortisone	Hydrocortisone	30	19
Trulicity	Dulaglutide	30	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	13
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	15
Glimepiride	Glimepiride	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	16
Shingrix	Varicella-Zoster Ge/As01b/Pf	25	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Glipizide Er	Glipizide	23	11
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	12
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	17	17
Lidocaine	Lidocaine	17	11
Synthroid	Levothyroxine Sodium	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Azithromycin	Azithromycin	16	15
Clotrimazole	Clotrimazole	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Atenolol	Atenolol	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Nystatin	Nystatin	14	suppressed
Prednisone	Prednisone	14	14
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Baclofen	Baclofen	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Linzess	Linaclotide	12	suppressed
Naproxen	Naproxen	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Diazepam	Diazepam	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error